← Back to home
Comparison · Analytics

GeneNMF vs Rho

A side-by-side editorial comparison of GeneNMF and Rho — release velocity, themes, recent moves, and the top alternatives to consider.

GeneNMF vs Rho: at a glance

FeatureGeneNMFRho
SectorAnalyticsAnalytics
Velocity score0.06.3
Sparks · 30d01
Top themessingle-cell-genomics, nmf, gene-programs, bioinformaticsr-ide, ai-agents, model-routing, release-engineering
Last editorial update54m ago11h ago
WebsiteVisit →Visit →

What is GeneNMF?

GeneNMF rebuilt how it derives meta-programs, changing every result it had produced.

GeneNMF applies non-negative matrix factorization to single-cell expression data to find gene programs, then consolidates programs recurring across samples into meta-programs. Version 0.6.0 replaced the consolidation method: instead of reducing each program to a gene set and taking a consensus, it retains full gene weight vectors and compares them by cosine similarity. Later releases have built reporting and control around that core — a metaprogram composition matrix showing which samples contributed, custom signature databases for enrichment testing, and the ability to drop meta-programs from results.

Read the full GeneNMF trajectory →

What is Rho?

Rho's release machinery is now more rigorous than the product it ships.

Rho is an R IDE in open prerelease, and its public feed is almost entirely release engineering. The one substantive entry, 0.4.0-dev.39, described capability-based model routing across providers and durable project-scoped agent conversations with per-file Apply/Undo. Everything around it is build candidates and acceptance targets, each gated behind an explicit acceptance record that fails closed.

Read the full Rho trajectory →

GeneNMF vs Rho: editorial side-by-side

G
GeneNMF
ANALYTICS
0.0

GeneNMF rebuilt how it derives meta-programs, changing every result it had produced.

◆ Current state

GeneNMF applies non-negative matrix factorization to single-cell expression data to find gene programs, then consolidates programs recurring across samples into meta-programs. Version 0.6.0 replaced the consolidation method: instead of reducing each program to a gene set and taking a consensus, it retains full gene weight vectors and compares them by cosine similarity. Later releases have built reporting and control around that core — a metaprogram composition matrix showing which samples contributed, custom signature databases for enrichment testing, and the ability to drop meta-programs from results.

◆ Where it's heading

The package is moving from producing meta-programs to letting users interrogate and constrain how they were formed. Composition matrices, the drop function and downsampled similarity heatmaps all serve inspection rather than derivation. The parameters added alongside the 0.6.0 rewrite — specificity weighting, cumulative weight thresholds, confidence defined as the fraction of programs containing a gene — turn what were fixed internal choices into stated, tunable ones.

◆ Prediction

Recent releases have been fixes and compatibility work rather than method changes, so the core approach appears settled. The dependency on an RcppML version not on CRAN is the loose end most likely to force the next release.

R
Rho
ANALYTICS
6.3

Rho's release machinery is now more rigorous than the product it ships.

◆ Current state

Rho is an R IDE in open prerelease, and its public feed is almost entirely release engineering. The one substantive entry, 0.4.0-dev.39, described capability-based model routing across providers and durable project-scoped agent conversations with per-file Apply/Undo. Everything around it is build candidates and acceptance targets, each gated behind an explicit acceptance record that fails closed.

◆ Where it's heading

The project is building an agentic R IDE but publishing like a regulated release process: signed evidence, CONDITIONAL_GO records, checksums bound to exact commits, limitations named out loud rather than buried. dev.41 exists solely to rehearse the native updater across Windows and macOS, which is the last piece of distribution infrastructure between a dev train and something installable by people who won't build from source. Feature work and shipping work are advancing on separate tracks.

◆ Prediction

The updater acceptance target points at a 0.4.0 line that can update itself, so the next entry that matters is either dev.40's real publication or the first build not labelled evaluation-only. Whether Windows signing moves off the SignPath trial certificate is the open question these entries leave unanswered.

Alternatives to GeneNMF and Rho

Other Analytics products tracked by Sparkpulse, ranked by recent ship velocity. Each card links to a full editorial trajectory and lets you pivot into a head-to-head comparison with either GeneNMF or Rho.

See all GeneNMF alternatives → · See all Rho alternatives →

Recent activity from GeneNMF and Rho

Latest ship moves from both products, interleaved chronologically. ⚡ = editorial spark.

  1. 17h agoRhoRho 0.4.0-dev.41 Native Updater Acceptance Target
  2. 4d agoRhoAgent conversations and provider-routed models land in Rho
  3. 8d agoRhoCross-platform candidate build awaiting acceptance evidence
  4. 23d agoRhoWindows installer build stamp for 0.2.0-dev.12
  5. 11mo agoGeneNMFSingle-sample runs fixed; gene weight definition refined
  6. 1y agoGeneNMFMetaprogram composition exposed and custom signature DBs supported
  7. 1y agoGeneNMFSimilarity heatmap downsampling and meta-program removal
  8. 2y agoGeneNMFMeta-programs rebuilt on gene weight vectors and cosine similarity
  9. 2y agoGeneNMFFirst stable release published to CRAN

Frequently asked questions

What is the difference between GeneNMF and Rho?

They serve adjacent needs but don't currently overlap on shipped themes. Rho is currently shipping more aggressively (velocity 6.3 vs 0.0), with 1 editorial sparks in the last 30 days against 0. See the at-a-glance table above for a side-by-side breakdown of velocity, recent sparks, and editorial themes.

Is GeneNMF better than Rho?

Sparkpulse doesn't pick a winner — we score release velocity, not feature parity. Rho is currently shipping more aggressively (velocity 6.3 vs 0.0), with 1 editorial sparks in the last 30 days against 0. For your specific use case, the alternatives sections above list other Analytics products to evaluate alongside.

What are the best alternatives to GeneNMF?

Top GeneNMF alternatives in Analytics are ranked by recent ship velocity. Browse the "GeneNMF alternatives" section above for the current picks, or visit /alternatives/genenmf for the full list with editorial commentary on each.

What are the best alternatives to Rho?

Top Rho alternatives in Analytics are ranked by recent ship velocity. Browse the "Rho alternatives" section above for the current picks, or visit /alternatives/yulab-smu-rho for the full list with editorial commentary on each.